Colin Johnson
University Surgical Unit
Southampton General Hospital
Southampton
UK
Name/email consistency: high
- Detection of gallstones in acute pancreatitis: when and how?. Johnson, C., Lévy, P. Pancreatology (2010)
- Antioxidants in acute pancreatitis. Johnson, C.D. Gut (2007)
- Combination of APACHE-II score and an obesity score (APACHE-O) for the prediction of severe acute pancreatitis. Johnson, C.D., Toh, S.K., Campbell, M.J. Pancreatology (2004)
- Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis. Johnson, C.D., Lempinen, M., Imrie, C.W., Puolakkainen, P., Kemppainen, E., Carter, R., McKay, C. Br. J. Surg (2004)
- Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Johnson, C.D., Abu-Hilal, M. Gut (2004)
- Early severity indexes in acute pancreatitis. Johnson, C.D. Acta Gastroenterol. Belg. (2003)
- Arris & Gale lecture. Regulation and responses of gallbladder muscle activity in health and disease. Johnson, C.D. Ann. R. Coll. Surg. Engl (2003)
- Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Johnson, C.D., Kingsnorth, A.N., Imrie, C.W., McMahon, M.J., Neoptolemos, J.P., McKay, C., Toh, S.K., Skaife, P., Leeder, P.C., Wilson, P., Larvin, M., Curtis, L.D. Gut (2001)
- Randomized, dose-finding phase III study of lithium gamolenate in patients with advanced pancreatic adenocarcinoma. Johnson, C.D., Puntis, M., Davidson, N., Todd, S., Bryce, R. Br. J. Surg (2001)
- Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis. Johnson, C.D. Dig. Surg (1999)